drugset / Trial / NCT06367075
A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
Phase 2
Recruiting
53 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
First Affiliated Hospital of Guangxi Medical University · collabSecond Xiangya Hospital of Central South University · collabSun Yat-Sen University Cancer Center · collabThe Affiliated Hospital Of Guizhou Medical University · collabXiangya Hospital of Central South University · collabYunnan Cancer Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, multicenter trial of cadonilimab (AK104) with adriamycin in patients with first-line advanced soft tissue sarcoma. the primary objective is to evaluate objective response rate of cadonilimab with adriamycin.
Timeline
- Start
- 2024-10-09
- Primary completion
- 2027-03-31
- Completion
- 2029-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cadonilimab | Monoclonal antibody | 10 mg/kg | — |
| Subject | Doxorubicin | Other / unclassified | 25 mg/m2 | — |